Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis

This study aimed to investigate the serum levels of the cytokine TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in patients with toxoplasmosis retinochoroidits (TR) and controls. 37 patients with TR and 30 subjects with positive serology for toxoplasmosis but without history and signs...

Full description

Bibliographic Details
Main Authors: Thais Fontes Bessa, Cynthia Azeredo Cordeiro, Roberto Martins Gonçalves, Lucy H. Young, Wesley R. Campos, Fernando Oréfice, Antônio L. Teixeira
Format: Article
Language:English
Published: Elsevier 2012-12-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600007
_version_ 1818245430522150912
author Thais Fontes Bessa
Cynthia Azeredo Cordeiro
Roberto Martins Gonçalves
Lucy H. Young
Wesley R. Campos
Fernando Oréfice
Antônio L. Teixeira
author_facet Thais Fontes Bessa
Cynthia Azeredo Cordeiro
Roberto Martins Gonçalves
Lucy H. Young
Wesley R. Campos
Fernando Oréfice
Antônio L. Teixeira
author_sort Thais Fontes Bessa
collection DOAJ
description This study aimed to investigate the serum levels of the cytokine TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in patients with toxoplasmosis retinochoroidits (TR) and controls. 37 patients with TR and 30 subjects with positive serology for toxoplasmosis but without history and signs of uveitis were included in this study. Serum concentrations of TNF-α, sTNFR1, and sTNFR2 were determined by ELISA. Serum concentrations of TNF-α and sTNFR1 were similar in controls (mean ± SD median values; 56.57 ± 141.96 and 504.37 ± 163.87, respectively) and TR patients (mean ± SD values, 121.62 ± 217.56 and 511.15 ± 189.30, respectively). Serum concentrations of sTNFR2 were higher in the uveitis group when compared to the control group (respectively, mean ± SD values, 1734.84 ± 379.32 and 1442.75 ± 309.47; p=0.002). There was no association between the serum levels of the molecules and the time of first symptoms, severity of vitreous haze, size or localization of active lesions, levels of visual acuity, and presence of vasculitis. These results suggest that TR is associated with changes in the circulating levels of inflammatory biomarkers, but they are not correlated with local/ocular signs.
first_indexed 2024-12-12T14:32:47Z
format Article
id doaj.art-4b7d4239933f4eaca608c105ceaafc8a
institution Directory Open Access Journal
issn 1413-8670
1678-4391
language English
last_indexed 2024-12-12T14:32:47Z
publishDate 2012-12-01
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-4b7d4239933f4eaca608c105ceaafc8a2022-12-22T00:21:28ZengElsevierBrazilian Journal of Infectious Diseases1413-86701678-43912012-12-0116654054410.1590/S1413-86702012000600007Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditisThais Fontes BessaCynthia Azeredo CordeiroRoberto Martins GonçalvesLucy H. YoungWesley R. CamposFernando OréficeAntônio L. TeixeiraThis study aimed to investigate the serum levels of the cytokine TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in patients with toxoplasmosis retinochoroidits (TR) and controls. 37 patients with TR and 30 subjects with positive serology for toxoplasmosis but without history and signs of uveitis were included in this study. Serum concentrations of TNF-α, sTNFR1, and sTNFR2 were determined by ELISA. Serum concentrations of TNF-α and sTNFR1 were similar in controls (mean ± SD median values; 56.57 ± 141.96 and 504.37 ± 163.87, respectively) and TR patients (mean ± SD values, 121.62 ± 217.56 and 511.15 ± 189.30, respectively). Serum concentrations of sTNFR2 were higher in the uveitis group when compared to the control group (respectively, mean ± SD values, 1734.84 ± 379.32 and 1442.75 ± 309.47; p=0.002). There was no association between the serum levels of the molecules and the time of first symptoms, severity of vitreous haze, size or localization of active lesions, levels of visual acuity, and presence of vasculitis. These results suggest that TR is associated with changes in the circulating levels of inflammatory biomarkers, but they are not correlated with local/ocular signs.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600007Toxoplasmosis UveitisTNF-alphaSoluble TNF receptors
spellingShingle Thais Fontes Bessa
Cynthia Azeredo Cordeiro
Roberto Martins Gonçalves
Lucy H. Young
Wesley R. Campos
Fernando Oréfice
Antônio L. Teixeira
Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
Brazilian Journal of Infectious Diseases
Toxoplasmosis Uveitis
TNF-alpha
Soluble TNF receptors
title Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
title_full Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
title_fullStr Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
title_full_unstemmed Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
title_short Increased serum levels of soluble tumor necrosis factor receptor-2 (sTNFR2) in patients with active toxoplasmic retinochoroiditis
title_sort increased serum levels of soluble tumor necrosis factor receptor 2 stnfr2 in patients with active toxoplasmic retinochoroiditis
topic Toxoplasmosis Uveitis
TNF-alpha
Soluble TNF receptors
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600007
work_keys_str_mv AT thaisfontesbessa increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT cynthiaazeredocordeiro increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT robertomartinsgoncalves increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT lucyhyoung increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT wesleyrcampos increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT fernandoorefice increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis
AT antoniolteixeira increasedserumlevelsofsolubletumornecrosisfactorreceptor2stnfr2inpatientswithactivetoxoplasmicretinochoroiditis